EB 148: WHO board paper on expanding access to effective treatments of cancer and rare and orphan diseases including cell and gene-based therapies

On 16 December 2020 the World Health Organization (WHO) published a paper that delighted in the name, Expanding access to effective treatments for cancer and rare and orphan diseases, including medicines, vaccines, medical devices, diagnostics, assistive products, cell- and gene-based… Continue Reading

KEI Files Amicus Brief in GlaxoSmithKline vs Teva Induced Infringement Case

(Updated for KEI’s corrected brief). On Wednesday December 16, 2020, Knowledge Ecology International (KEI) filed an amicus curiae brief in GlaxoSmithKline LLC v. Teva Pharmaceuticals USA, Inc. (“GSK”, “Teva”). The case concerns secondary indications of medicines, and whether Teva induced… Continue Reading

South Africa on fire: closing innings at the WTO TRIPS Council (10 December 2020)

UPDATE (16 December 2020): The WTO General Council is meeting from Wednesday, 16 December 2020 to Friday, 18 December 2020 to discuss a number of matters including e-commerce, cotton, and TRIPS Council matters. Under agenda item 13, the Chair of… Continue Reading

KEI Comments on NIH Proposed Exclusive Patent License to St. Louis University for Treatment and Prevention of Neuropathic Pain With P2Y14 Antagonists

On December 3, 2020, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) regarding the “Prospective Grant of Exclusive Patent License: Treatment and Prevention of Neuropathic… Continue Reading

$1.8 Billion Sanofi Vaccine Contract Contains International Reference Pricing Clause, Preserves Standard IP and Data Rights

The contract awarding Sanofi Pasteur (“Sanofi”) 1.8 billion U.S. taxpayers’ dollars for the development and manufacture of a COVID-19 vaccine was posted in the Department of Health and Human Services (HHS) Electronic Reading Room on November 30, 2020. Overall, the… Continue Reading

Foundational mRNA patents are subject to the Bayh-Dole Act provisions

Katalin Karikó and Drew Weissman are often described as the pioneers of the mRNA discoveries that underpin the first COVID-19 vaccines. In 2005 both scientists published a paper reporting that a slightly tweaked version of mRNA that can be administered… Continue Reading

KEI comments to FDA on Prospective Exclusive Patent License for Diagnostic for SARS, SARS-CoV-2, Other Viruses, Bacteria and Bacterial Serovar, to Advion

To: Ken Millburne Technology Transfer Program Food and Drug Administration Via email: Kenneth.millburne@fda.hhs.gov From: James Love Knowledge Ecology International 1621 Connecticut Avenue NW, Suite 500 Washington, DC 20009 https://keionline.org Date: November 30, 2020 Re: Prospective Grant of an Exclusive Patent… Continue Reading

Musical chairs: WIPO unveils new leadership team

UPDATE: On Friday, 27 November 2020, the World Intellectual Property Organization (WIPO) published document WO/CC/79/2, Appointment of Deputy Directors General and Assistant Directors General, in all six United Nations languages (Arabic, Chinese, English, French, Russian, and Spanish) confirming the information… Continue Reading

WTO TRIPS Council – 20 November 2020 – South Africa’s defense of the TRIPS waiver

On Friday, 20 November 2020, the World Trade Organization (WTO) convened an informal, virtual meeting of the TRIPS Council to discuss a proposal (IP/C/W/669) co-sponsored by Eswatini, India, Kenya, and South Africa for a waiver from certain provisions of the… Continue Reading